BCA
ABBV icon

Bay Capital Advisors’s AbbVie ABBV Stock Holding History

Bay Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749K Sell
2,976
-134
-4% -$28.8K 0.4% 44
2026
Q1 		$676K Sell
3,110
-25
-0.8% -$5.55K 0.42% 46
2025
Q4 		$716K Hold
3,135
– – 0.44% 46
2025
Q3 		$726K Hold
3,135
– – 0.47% 41
2025
Q2 		$582K Sell
3,135
-1
-0% -$186 0.44% 53
2025
Q1 		$657K Buy
3,136
+8
+0.3% +$1.55K 0.55% 44
2024
Q4 		$556K Buy
+3,128
New +$575K 0.45% 55

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Bay Capital Advisors's ABBV Position: Q2 2026 in Review

Bay Capital Advisors reduced its AbbVie (ABBV) stake by 4.3% in Q2 2026, selling an estimated $28.8K and leaving 2,976 shares worth $749K. The position accounts for 0.4% of the portfolio, ranked #44.

Bay Capital Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bay Capital Advisors held 2,976 shares of AbbVie worth $749K as of Q2 2026.
  • Bay Capital Advisors sold 134 AbbVie shares in Q2 2026, an estimated $28.8K.
  • AbbVie made up 0.4% of Bay Capital Advisors's portfolio in Q2 2026, its #44 holding.
  • Bay Capital Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bay Capital Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.